Literature DB >> 2894494

Detrimental haemodynamic effects of cyclizine in heart failure.

L B Tan1, S Bryant, R G Murray.   

Abstract

The haemodynamic effects of intravenous cyclizine, an antiemetic that is widely given with opioids in left ventricular failure and myocardial infarction, were studied in 11 patients with severe heart failure. Cyclizine significantly increased systemic and pulmonary arterial pressures, and right and left ventricular filling pressures, and negated the venodilatory effects of diamorphine. The use of cyclizine in patients with heart failure should, therefore, be avoided.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894494     DOI: 10.1016/s0140-6736(88)91354-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure.

Authors:  S G Williams; D J Wright; P Marshall; A Reese; B-H Tzeng; A J S Coats; L-B Tan
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Use of intravenous cyclizine in cardiac chest pain.

Authors:  R A Cooke; M W Cooke
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

Review 3.  Advances in the early diagnosis and management of acute myocardial infarction.

Authors:  R Vincent
Journal:  J Accid Emerg Med       Date:  1996-03

Review 4.  Best evidence topic report. Use of intravenous cyclizine in cardiac chest pain.

Authors:  Gabby May; Ricky Kumar
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

Review 5.  Management of end stage cardiac failure.

Authors:  Miriam J Johnson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 6.  Treatment of nausea and vomiting in terminally ill cancer patients.

Authors:  Paul A Glare; David Dunwoodie; Katherine Clark; Alicia Ward; Patsy Yates; Sharon Ryan; Janet R Hardy
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  Treating nausea and vomiting in palliative care: a review.

Authors:  Paul Glare; Jeanna Miller; Tanya Nikolova; Roma Tickoo
Journal:  Clin Interv Aging       Date:  2011-09-12       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.